Sernova Biotherapeutics Inc., 2026-02-05
An SEC Form D private-offering notice from Mississauga, ON, Canada, a $843,153 filer-stated offering target in Biotech. Filed 2026-02-05. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Clinical stage regenerative medicine company developing the Cell Pouch, a bio hybrid implantable organ system, currently in trials for type 1 diabetes; trades on the TSX as SVA.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- LUREX BIO, INC, 2026-02-05, Fort Lauderdale, FL
- PathCision Medicine, Inc., 2026-02-05, $3M, Watertown, MA
- Nanochon, Inc., 2026-02-05, $4.2M, Washington, DC
- Gilgamesh Pharma Inc., 2026-02-04, $6.1M, New York, NY
- Conexeu Sciences Inc., 2026-02-04, $810K, Reno, NV
- Sentire Medical Systems, Inc., 2026-02-04, $1.2M, Palm Beach Gardens, FL
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.